Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
Savannah E. Butler, Andrew R. Crowley, Harini Natarajan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 475-484
Open Access | Times Cited: 530
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Vivek P. Chavda, Lalitkumar K. Vora, Anjali Pandya, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2619-2636
Open Access | Times Cited: 188
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
Mrunal Sakharkar, C. Garrett Rappazzo, Wendy Wieland‐Alter, et al.
Science Immunology (2021) Vol. 6, Iss. 56
Open Access | Times Cited: 185
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Katharina Röltgen, Scott D. Boyd
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1063-1075
Open Access | Times Cited: 127
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 381-396
Open Access | Times Cited: 124
Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?
Mattia Tiboni, Luca Casettari, Lisbeth Illum
International Journal of Pharmaceutics (2021) Vol. 603, pp. 120686-120686
Open Access | Times Cited: 104
Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
Janeri Fröberg, Joshua Gillard, Ria Philipsen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 81
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Wen Shi Lee, Kevin J. Selva, Samantha K. Davis, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 6, pp. 100296-100296
Open Access | Times Cited: 77
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 71
Natural killer cell‐mediated ADCC in SARS‐CoV‐2‐infected individuals and vaccine recipients
Kerri Hagemann, Kristoffer Riecken, Johannes M. Jung, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 8, pp. 1297-1307
Open Access | Times Cited: 60
The role of B cells in COVID-19 infection and vaccination
Shiru Chen, Fei Guan, Fabio Candotti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people
Tara M. Narowski, Kristin Raphel, Lily E. Adams, et al.
Cell Reports (2022) Vol. 38, Iss. 5, pp. 110336-110336
Open Access | Times Cited: 49
Guardians of the oral and nasopharyngeal galaxy: IgA and protection against SARS‐CoV‐2 infection*
Salma Sheikh‐Mohamed, Erin C. Sanders, Jennifer L. Gommerman, et al.
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 75-85
Open Access | Times Cited: 46
Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection
Peter F. Wright, Alejandra Prevost-Reilly, Harini Natarajan, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 7, pp. 1204-1214
Open Access | Times Cited: 43
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Andrew R. Crowley, Harini Natarajan, Andrew P. Hederman, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Dennis Lapuente, Thomas Winkler, Matthias Tenbusch
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 144-158
Open Access | Times Cited: 29
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
C. Pierre, Lily E. Adams, Jaclyn S. Higgins, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1011569-e1011569
Open Access | Times Cited: 11
IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
Benjamin Haslund-Gourley, Kyra Woloszczuk, Jintong Hou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
Marco Brustolin, Jordi Rodon, Maria Luisa Rodrı́guez de la Concepción, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 797-809
Open Access | Times Cited: 51
Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction
Sven Saussez, Shilpee Sharma, Anaïs Thiriard, et al.
European Journal of Neurology (2021) Vol. 28, Iss. 11, pp. 3702-3711
Open Access | Times Cited: 45
Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
Yaozong Chen, Lulu Sun, Irfan Ullah, et al.
Science Advances (2022) Vol. 8, Iss. 28
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top